Evidence map›Paper›PMID 41034928›Full record

ReviewJournal of translational medicine2025

Crosstalk between lymphatic system and synovial inflammatory cells in osteoarthritis: molecular mechanisms and potential cell-based therapies.

Wang Zeng, Jiangyu Xiang, Yang Liu, Shirong Chen, Hao Wang

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wang Zeng *Department of Orthopedic Surgery, Center for Joint Surgery, The Second Affiliated Hospital of Chongqing Medical University, Linjiang Road No.76, Yuzhong District, Chongqing, 400010, China.
Jiangyu Xiang *Department of Orthopedic Surgery, Center for Joint Surgery, The Second Affiliated Hospital of Chongqing Medical University, Linjiang Road No.76, Yuzhong District, Chongqing, 400010, China.
Yang LiuDepartment of Orthopedic Surgery, Center for Joint Surgery, The Second Affiliated Hospital of Chongqing Medical University, Linjiang Road No.76, Yuzhong District, Chongqing, 400010, China.
Shirong ChenDepartment of Orthopedic Surgery, Center for Joint Surgery, The Second Affiliated Hospital of Chongqing Medical University, Linjiang Road No.76, Yuzhong District, Chongqing, 400010, China. chensr@hospital.cqmu.edu.cn.
Hao WangDepartment of Orthopedic Surgery, Center for Joint Surgery, The Second Affiliated Hospital of Chongqing Medical University, Linjiang Road No.76, Yuzhong District, Chongqing, 400010, China. haowang@hospital.cqmu.edu.cn.ORCID 0009-0003-4868-4587

Funding

Natural Science Foundation of Chongqing Municipality CSTB2022NSCQ-MSX0052Natural Science Foundation of Chongqing Municipality CSTB2023NSCQ-BHX0096
6 · The paper itself

Abstract

The lymphatic system plays a significant part in interstitial fluid balance and immune surveillance throughout the whole body. In addition, recent studies have elucidated the role of the lymphatic system in maintaining the normal function of joints, and its dysfunction is related to the pathogenesis of osteoarthritis (OA). In this review, we described the composition and function of the lymphatic system in the knee joints and summarized the research progress of lymphatic networks in the development of OA. The synovial lymphatic system (SLS) is the most well-characterized lymphatic network, and we elaborated the pathological changes of SLS which resulted in the disturbance of knee joint homeostasis and the progression of OA. We summarized the underlying molecular mechanisms of lymphatic disorders and focused on the crosstalk between the SLS and synovial inflammatory cells, especially the abnormal macrophage polarization and regulatory T cells dysfunction. Cell-based therapies have been proven to restore lymphatic function. This review proposed potential cell-based therapies to treat OA by targeting the SLS, and mesenchymal stem cells and Tregs based therapies are currently the most promising approaches to treat OA by restoring lymphatic flow.

Indexed as

Cell- and Tissue-Based TherapyInflammationLymphatic SystemOsteoarthritisSynovial MembraneAnimalsHumansCell-based therapyCell interactionLymphatic systemOsteoarthritis

Identifiers

PMID41034928
PMCPMC12487544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.